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Abstract 
Background: Timely but accurate data collection is needed during health emergencies to inform public health 
responses. Often, an abundance of data is collected but not used. When outbreaks and other health events occur 
in remote and complex settings, operatives on the ground are often required to cover multiple tasks whilst working 
with limited resources. Tools that facilitate the collection of essential data during the early investigations of a potential 
public health event can support effective public health decision-making. We proposed to define the minimum set of 
quantitative information to collect whilst using electronic device or not. Here we present the process used to select 
the minimum information required to describe an outbreak of any cause during its initial stages and occurring in 
remote settings.
Methods: A working group of epidemiologists took part in two rounds of a Delphi process to categorise the vari-
ables to be included in an initial outbreak investigation form. This took place between January–June 2019 using an 
online survey.
Results: At a threshold of 75 %, consensus was reached for nineteen (23.2%) variables which were all classified as 
‘essential’. This increased to twenty-six (31.7%) variables when the threshold was reduced to 60% with all but one 
variable classified as ‘essential’. Twenty-five of these variables were included in the ‘Time zero initial case investigation’ 
‘(T0)’ form which was shared with the members of the Rapid Response Team Knowledge Network for field testing and 
feedback. The form has been readily available online by WHO since September 2019.
Conclusion: This is the first known Delphi process used to determine the minimum variables needed for an outbreak 
investigation. The subsequent development of the T0 form should help to improve the efficiency and standardisation 
of data collection during emergencies and ultimately the quality of the data collected during field investigation.
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Background
The rapid investigation of potential public health events1 
is key to mitigating the harmful effects of these. Opera-
tives on the ground during the early phases of a public 
health event are often required to cover multiple tasks 
whilst working with limited resources. When outbreaks 
and other health events occur in remote and complex 
settings, these problems can be multiplied. Tools that 
facilitate the accurate, rapid and efficient collection of 
essential data during the early investigation of a potential 
public health event can support effective public health 
decision-making, whilst adding minimal additional bur-
den to the work of field investigators.
Whilst much attention has been given to the develop-
ment of analytic tools which aim to facilitate timely anal-
ysis and prediction during complex outbreaks, there have 
been fewer reports which emphasise the need for quality, 
completeness and timeliness of primary data collection at 
the field level [1].
At present, there is significant variability in the qual-
ity of epidemiological information generated during out-
break investigations. During the 2014–2015 West African 
Ebola virus disease outbreak, a number of inadequacies 
in data management were reported, including reports of 
incomplete case investigation forms and the late arrival 
of data [2] and the challenges to properly label and clas-
sify samples sent to the labs during the investigation. The 
absence of a central database aimed at linking different 
sources of data was highlighted as a crucial problem [2] 
as was the variability of formats from different sources 
preventing the merger of information and the surfeit of 
detailed data that were collected but never used in anal-
yses [3]. Studies conducted in South-East Asia and in 
Europe have also found that a number of data sets col-
lected for outbreak reports were incomplete and/or inac-
curate [4, 5]. Combined, the problems of incomplete, 
delayed, incorrect, excessively detailed and disorganised 
data sets are the key factors that result in an inability to 
rapidly assess and report critical indicators on the nature 
and risks posed by a potential health event. Those obser-
vations have been reported for several years and from all 
over the world.
In resource-limited settings, it is imperative to maxim-
ise efficiency by focussing on the primary objectives of 
data acquisition and to include only variables which may 
directly inform the immediate response. Alongside this, 
the methods of data collection and management need 
to be considered, with particular focus on the need to 
link multiple data sources and standardise variables for 
downstream data processing.
In response to the need for standardized data collec-
tion instruments for early investigations of public health 
events, the Health Emergencies Program (WHE) of the 
World Health Organization (WHO) proposed in 2018 
to develop the WHO Outbreak Toolkit (WHO-OT), a 
novel resource which aims to improve the quality, timeli-
ness and use of data during public health events through 
a web-based application for field staff. The WHO-OT 
includes a set of documents providing information about 
diseases, standardized case definitions, case report forms, 
laboratory guidelines and standards for data collection 
[6]. The WHO-OT project adheres to the key epidemio-
logical principles of outbreak investigation, which are to 
provide an initial description of the situation with regard 
to the time, place and person. This should allow for 1) an 
informed assessment of severity and risk of progression 
of the outbreak, 2) the opportunity to generate hypoth-
eses regarding the potential sources of the hazard(s) and 
mode of transmission, and 3) to establish whether fur-
ther laboratory and epidemiological investigations are 
needed. The WHO-OT project therefore will comprise a 
set of tools which enable field staff to correctly collect the 
minimal necessary data for outbreaks (both infectious 
and non-infectious) of known and unknown cause.
The Delphi process is used to develop consensus 
amongst a group of experts [7], particularly where there 
may be little existing evidence for a specific issue [8]. 
It uses structured group communication through an 
iterative multistage process [9]. WHO has successfully 
used the Delphi process in multiple contexts, includ-
ing recently to define the priority diseases for the WHO 
Research and Development Blueprint [10].
This paper describes the process used to identify and 
refine the minimum variables needed during the initial 
stages of any public health event investigation.
Methods
In June 2018, WHO convened a working group consti-
tuted of 36 experts in epidemiology, clinical medicine, 
environmental sciences, data management and data sci-
ences who worked in organisations including WHO, the 
United States Centers for Disease Control (US-CDC), 
Médecins Sans Frontières (MSF), the European Centre 
for Disease Prevention and Control (ECDC), the Lon-
don School of Hygiene & Tropical Medicine (LSHTM), 
the Helmholtz Centre for Infection Research, and Oxford 
University. These participants belonged to international 
organisations involved in field outbreak investigations 
and were considered experts in working in epidemics 
1 A public health event is any event that may have negative consequences 
for human health. The term includes events that have not yet led to disease 
in humans but have the potential to cause human disease through exposure 
to infected or contaminated food, water, animals, manufactured products or 
environments. In contrast, an outbreak denotes that the event has already 
caused disease (WHO definition).
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in low- and middle-income countries (LMICs). The list 
of participants was established based on a list of WHO 
experts in health event investigations, existing working 
relationships with WHO external partners in data col-
lection, recommendations from experts consulted dur-
ing recent work for the investigation of outbreaks of 
unknown origin, and partner institution experts involved 
in field data collection for all hazards. Terms of refer-
ences of the working group were circulated and agreed 
during a first teleconference in June 2018.
The working group was invited to participate in the 
process of selecting a set of minimum variables (defined 
as ‘Epi Core Variables’) for event investigations under 
the WHO-OT project. This process commenced with 
a review of thirty-one case investigation forms from a 
range of sources from WHO, US-CDC, MSF, Interna-
tional Federation of Red Cross (IFRC) which had been 
used in previous health events and included both infec-
tious and non-infectious hazards. From this, the partici-
pants selected variables which were common to a generic 
outbreak situation rather than specific for any pathogen 
or disease aetiology. These variables, called the “initial 
list”, contained 82 variables grouped into four categories: 
1) Notification interview, 2) Case information, 3) Clinical 
information and 4) Exposure (Additional  file  1). Ques-
tions for each variable were phrased in a way that would 
allow them to be used in any type of health event, whilst 
also ensuring the data to be comparable across situations. 
Variables describing clinical signs and symptoms were 
grouped into two sub-groups including (a) those charac-
terising the severity of any disease and (b) those covering 
signs and symptoms; Only variables that characterise the 
severity of any disease, (a), were included in the prioriti-
zation exercise.
In order to reach consensus on which of the variables 
should classified as ‘Epi Core’, the working group decided 
to use a Delphi process.
Prioritisation of variables was restricted to a sub-group 
of 26 members of the working group in order to keep a 
balance among members from different institutions and 
to restrict the group to experts with regular participa-
tion in field outbreak investigations. We conducted the 
Delphi via an online survey tool in two stages conducted 
between January 2019 and June 2019 using Enketo web-
forms [11]. Delphi participants were sent a guidance doc-
ument for the process which outlined the purpose of the 
selection of variables. The variables were ordered by cat-
egories and accompanied by a description. This allowed 
the experts to prioritise the importance of including 
these as ‘Epi Core variables’ as defined in Table  1. For 
each variable, this sub-group of participants were asked 
to determine whether the variable should be retained for 
inclusion, and if so, to assign its priority in data collec-
tion during an outbreak as essential, high, medium, low 
or unknown (Table  1). The priority classification serves 
to adapt to the resources available in the field at the time 
of the outbreak investigation, i.e. if resources are limited, 
the field officer should collect at a minimum the essential 
variables. Experts could also provide additional explana-
tory comments in relation to their categorisations.
In January 2019, all 26 members of the sub-group were 
sent invitations by email to participate in the first round 
of the Delphi process. Participants were given 55 days to 
complete the survey. Automated reports of the aggre-
gated results and any additional comments from the first 
round were generated using R statistical software (ver-
sion 3.5.3) and were sent to all participants in March 
2019, and 25 members of the sub-group were sent invi-
tations to participate in the second round for which the 
methods were the same. Two additional participants 
were added to the second round to account for a loss to 
follow-up of three participants after the first round.
Those variables for which a priority classification 
reached at least 75% consensus during the first round, 
were excluded from the second round. In a systematic 
review of English language Delphi studies, the most com-
mon definition for consensus was percentage agreement, 
with 75% being the median threshold to define con-
sensus [12]. Similar to the first round, 75% was used as 
the threshold for variables to be included in the second 
round.
Participants were given 26 days to respond before 
reports of the results from both the first and second 
round were disseminated. Following this, all participants 
Table 1 The priority classification and definition of the categorisation of the variables
Category of prioritisation Definition
Essential Mandatory variables that should appear on all outbreak investigation forms
High Variables which are highly desirable however not essential
Medium Variables which are recommended to be collected when feasible. These should be 
considered when facing an unusual outbreak that triggers the need for more detailed 
information, e.g. a novel form of a disease, a changing epidemiological pattern of a 
known disease, or the suspicion of new risk factors.
Low Other variables which should be collected when feasible in order to refine the analysis
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were invited to a teleconference to discuss the results, in 
which 13 attended. Given the limited number of variables 
which reached a consensus of 75% and the large spread of 
the results, the group decided to broaden consideration 
of variables which reached a consensus at 60%. Therefore, 
we also show those variables which reached at least 60% 
consensus.
The minimum set of variables served to develop a 
generic data collection form for outbreak investiga-
tion, nominally titled the ‘T0 initial case investigation 
form’ (“T” for time, “0” for first data collection), to 
collect the minimum set of data to describe an out-
break of any origin and to build initial hypotheses 
regarding its origin/source, transmission, aetiology or 
syndrome. Given that not all of the working group had 
a clinical background, the Delphi process was only 
used to facilitate the prioritisation of signs of sever-
ity of disease. A sub-group of medical experts then 
selected pathogen- or syndrome-specific variables 
from those medical variables included in the initial 
list of 82 variables (Additional file  1) to be included 
in the T0 form. WHO laboratory experts were con-
sulted to define variables for laboratory diagnosis to 
be included in the form.
The T0 form was field tested by members of the 
National Rapid Response Teams Knowledge Network 
(RRT KN) in French and English-speaking countries. 
Feedback was received from three countries, Tunisia, 
Egypt, Morocco and the Eastern Mediterranean Public 
Health Network (EMPHNET) who tested the T0 during 
training of Rapid Response Teams. The field-testing led 
to the inclusion of additional variables, mainly pertain-
ing to exposure, included in the list as essential in the 
T0 form following the recommendations issued from 
field practitioners in the testing process. One variable, 
‘neighbourhood/camp/settlement’, was deleted following 
results of the field-testing.
Results
Eighty-two variables were selected to be included in 
the Delphi survey by the sub-group with epidemio-
logical outbreak expertise. Out of 82, nine (11.0%) were 
categorised as being related to the notification of a case 
such as the date and location, 31 (37.8%) related to the 
demographics of the case, 17 (20.7%) to clinical informa-
tion, and 25 (30.5%) to exposure to the hazard. The list of 
variables by categories is given in the supplementary data 
(Additional file 1 ).
Sixteen (61.5%) members of the working group 
responded to the first-round of the Delphi survey and 17 
(68%) to the second round. The distribution of partici-
pants and responses by organisational group is shown in 
Table 2. In both rounds, the majority of participants were 
from WHO, (61.5 and 60%, respectively).
Consensus for the classification into the categories 
was reached for nineteen variables (23.2%) using a 
threshold of at least 75% (Table  3). All nineteen vari-
ables were classified as essential (Tables  4, 5, 6 and 7). 
On reduction of the threshold for consensus to at least 
60%, the number of variables increased to 26 (31.7%) of 
which 25 variables were classified as essential and one 
variable was classified as high (Tables 3, 4, 5, 6 and 7). 
Consensus was highest amongst those related to case 
information: 35.5% at a threshold of 75% consensus and 
45.2% at a threshold of 60% consensus; and lowest for 
those related to exposure: 8.0% at a threshold of 75% 
consensus and 12.0% at a threshold of 60% consensus 
(Table 3).
The highest consensus for any variable ranged from 
31.3% (n = 5) to 100% (n = 1) (Tables  4, 5, 6, 7 and 
Additional file 2).
The tested version of the T0 initial investigation 
form comprises 43 (52.4%) of the variables from the 
Delphi process, which included all of those which 
reached consensus at 75% and all of those which 
reached consensus at 60% except one indicated 
above (Tables 4, 5, 6 and 7). In addition to the epide-
miologic variables, eleven clinical variables from the 
initial list were added describing the syndrome and 
severity of the status of the patient. To those clinical 
variables, quantitative criteria were also added in the 
T0 form following recommendations of the medical 
sub-group of experts. Tables 4, 5, 6 and 7 show that 
most of the variables selected via the Delphi process 
Table 2 Number and Response rates to the first and second round of the Delphi survey by organization
Organisation of participants Number of participants survey 
sent to (first round/second round)
Number who responded to the 
first round and response rate (%)
Number who responded to the 
second round and response rate 
(%)
WHO 16 / 15 8 (50.0) 10 (66.7)
Academia 5 4 (80.0) 3 (60.0)
International organisations 5 4 (80.0) 4 (80.0)
Total 26 / 25 16 (61.5) 17 (68.0)
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relate to the socio-demographic and epidemiology 
criteria while those related to exposure to agent or 
mode of transmission were selected during the field 
testing phase.
The highest score refers to the highest percentage given 
for any priority category. The final category refers to the 
priority assigned based on reaching consensus at 60%. 
"X" indicates whether the category was selected by the 
medical sub-group; included as result of field testing of 
the T0 form and whether it was included in the final T0 
form.
Discussion
The importance of developing minimum datasets 
for emerging infectious diseases has been previously 
described in relation to the design of clinical trials how-
ever, this is the first known attempt to determine the 
core epidemiological information to be collected during 
outbreaks based on an all-hazards approach [13]. We 
describe here an approach that allowed a working group 
from various countries and organisations to participate 
remotely in a flexible way.
At a threshold of 75%, only 28% of variables included 
in the Delphi survey reached consensus and even at a 
threshold of 60% we achieved 39% consensus. Our con-
sensus levels were lower than in a systematic review of 
one-hundred manuscripts where close to 88% reached 
consensus [12]. We may have achieved a greater per-
centage of variables reaching consensus if the cat-
egorisation was less specific, such as by limiting it to 
‘essential’ and ‘non-essential’ only. Additionally, the 
background of the working group varied particularly 
regarding their level of clinical expertise and the path-
ogens which with they were familiar, which may have 
influenced some results and potentially resulted in 
response bias.
The final output of the work is the T0 form, a generic 
data collection form for outbreak investigations, devel-
oped to describe an outbreak and to build hypotheses 
regarding its origin/source, transmission, cause and/or 
Table 3 The number of variables and the number and percentage of variables which reached consensus by group
Group Number of variables at the 
start of the process
Number of variables that reached 
consensus at 75% in either round (%)
Number of variables that reached 
consensus at 60% in either round 
(%)
Notification interview 9 2 (22.2) 4 (44.4)
Case information 31 11 (35.5) 14 (45.2)
Clinical information 17 4 (23.5) 5 (29.4)
Exposure 25 2 (8) 3 (12.0)
Total 82 19 (23.2) 26 (31.7)
Table 4 List of variables included in the Delphi process as part of the ‘Notification Interview’ and score of consensus obtained in the 
two rounds of the survey with final priority category, decision of the medical sub-group and of the field testing results to preserve and 
final decision to include in the T0









Field testing Included 
in the T0 
form
Case ID number 100 NA Essential X
Date case reported 81.3 NA Essential X
Case reported by 43.8 35.3 NA X X
Name of reporting facility 68.8 41.2 Essential X
Interviewer’s identification 31.3 35.3 NA X
Interviewer’s organization 31.3 47.1 NA X X
Interview date 31.3 64.7 Essential X
Name of person interviewed (if not the case) 37.5 35.3 NA
Relation of person interviewed to the case (if 
not the case)
31.3 35.3 NA
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Table 5 List of variables included in the Delphi process as part of the ‘Case Information’
a indicates that the variable has been withdrawn from the list of epi-core variables after the field testing








Field testing Included in 
the T0 form
Surname/Last name 75 NA Essential X
First and second names 75 NA Essential X
Nickname 37.5 35.3 NA
Father/mother/guardian (first and last name) 37.5 41.2 NA
Head of household (first and last name) 50 52.9 NA
Telephone number 50 47.1 NA X X
Date of birth 75 NA Essential X
Age at onset (years) 81.3 NA Essential X
Age at onset in months 62.5 70.6 Essential X
Sex 93.8 NA Essential X
Nationality 50 41.2 NA
Ethnic group 43.8 52.9 NA
Status (refugee, resident, traveler, displaced) 37.5 47.1 NA
Language spoken at home 37.5 41.2 NA
Occupation/profession 50 41.2 NA X X
If other occupation, specify 31.3 47.1 NA
Works in health facility 56.3 41.2 NA X X
Residential/street address 87.5 NA Essential X
Neighborhood/camp/settlement 68.8 58.5 Essential a
Landmarks to locate the house 43.8 41.2 NA
Village/Town/City 93.8 NA Essential X
Postcode/ZIP 43.8 41.2 NA
Administrative level 4 of residence 81.3 NA Essential X
Administrative level 3 of residence 75 NA Essential X
Administrative level 2 of residence 75 NA Essential X
Administrative level 1 of residence 75 NA Essential X
Country 68.8 47.1 Essential X
GPS latitude 50 41.2 NA X X
GPS longitude 50 41.2 NA X X
Table 6 List of variables included in the Delphi process as part of the ‘Clinical Information’
Variable Highest score (first 
round) (%)






Field testing Included in 
the T0 form
Date of illness onset 93.8 NA Essential X
Admitted to hospital 75 NA Essential X
Outcome of illness 93.8 NA Essential X
Duration of symptoms (days) 25 29.4 NA
Date of death 87.5 NA Essential X
Pregnancy 43.8 58.8 NA X X
Underlying conditions 31.3 35.3 NA X X
Did the patient receive antibiotics prior to 
admission/specimen collection?
68.8 35.3 High X X
Chronic disease 31.3 35.3 NA X X
Malnutrition 31.3 41.2 NA X X X
Shock 43.8 47.1 NA X X
Intense pain 25 35.3 NA X X
Abnormal bleeding 37.5 41.2 NA X X X
Intense fatigue (lethargy) or weakness 31.3 29.4 NA X X
Other signs and symptoms, specify 43.8 29.4 NA X X
Conscious disorder 43.8 47.1 NA X X X
Shortness of breath 43.8 52.9 NA
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clinical syndrome. To facilitate data collection in a vari-
ety of settings, including areas lacking data connectivity, 
the T0 has been converted into formats to enable elec-
tronic data capture including: KoBoCollect, Go. Data, 
and the Early Warning, Alert and Response System 
(EWARS) [14]. In order to standardise the data and to 
optimise sharing and analysis, a data dictionary for the 
T0 form was also developed and made available on the 
website of the Outbreak Toolkit Project. Our objective 
is to stimulate the use of electronic data capture tools in 
the field.
The T0 form served as the basis for the urgent devel-
opment of a coronavirus disease 2019 (COVID-19) 
case based surveillance form that was shared with all 
countries and which allowed to rapidly collect the mini-
mum information needed to monitor the COVID-19 
pandemic [15, 16]. The variables of the T0 form have 
also served as the backbone for the development of a 
Time 1 (T1) questionnaire for investigation of unknown 
diseases, with a greater focus on clinical symptoms and 
laboratory results and which is available on demand. The 
development of the T1 questionnaire was conducted 
separately to the Delphi process.
We hope that this first attempt to develop a standard 
questionnaire to be used at the start of any outbreak 
investigation will continuously be revised by those using 
it. Also the principle of a generic questionnaire, devel-
oped as a tool to support field epidemiologists, implies 
Table 7 List of variables included in the Delphi process as part of the ‘Exposure’












Field testing Included 
in the T0 
form
Participation in mass gatherings 56.3 58.8 NA X X
 If yes, type of mass gathering/s 43.8 35.3 NA X X
 If yes, locations of mass gatherings 37.5 29.4 NA X X
 If yes, dates of mass gatherings 37.5 29.4 NA X X
Number of household members 37.5 41.2 NA
Recently or currently sick household members 56.3 NA NA
Name of sick household member/s 37.5 41.2 NA
Relationship with sick household member/s 31.3 35.3 NA
Sick household member outcomes 31.3 29.4 NA
Sick household member date of onset 37.5 41.2 NA
Community members currently sick with a similar illness 
or were sick with one within the last XX weeks/months?
43.8 41.2 NA
Other sick community members – names 37.5 41.2 NA
Relationship with the sick community member 31.3 41.2 NA
Places of interaction with the community member (e.g. 
market or church) in the XX weeks/months prior to fall-
ing ill
31.3 29.4 NA
Approximate date of onset of illness for the community 
member
37.5 41.2 NA
Outcome of community member’s illness 31.3 29.4 NA
Did you have any direct contact with any people with 
similar illness/symptoms in the XX weeks/months prior 
to the onset of illness?
62.5 52.9 Essential X X
Relationship with symptomatic person 37.5 35.3 NA X X
Provides the location/s the respondent had contact with 
the symptomatic person/s
37.5 52.9 NA X X
Date of last contact with the person whilst they were 
symptomatic
43.8 58.8 NA X X
Name of symptomatic contact 43.8 47.1 NA
Have you travelled outside of your current town/village/
city sinceXX weeks/months prior to symptom onset?
75 NA Essential X
Travel history locations 75 NA Essential X
 If yes Travel history dates 43.8 35.3 NA X
 If yes Travel history activities 43.8 29.4 NA
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that it should be adapted to the specific outbreak context 
at the start of the investigation.
Conclusions
This is the first reported systematic Delphi process which 
aimed to define a common set of core variables to be 
included in an initial case investigation form for outbreak 
investigations. This tool will support the global standard-
isation of data collection during the early stage of public 
health events, allowing for improved efficiency and time-
liness of data capture in challenging settings.
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